Symbol
X4 Pharmaceuticals, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$0.21
Current price of the stock
$2M
Trading volume of the stock
$43.1M
Market capitalization of the company
Nano Cap
Category of market capitalization
-
Long-term growth mean estimate
5.00
Mean analyst rating
1064.96%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
1.26
Total debt to total equity ratio
4.89
Current ratio
59.46%
Gross profit margin
-6160.71%
Operating profit margin
-6160.71%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-6550.18%
Pretax profit margin
-6552.86%
Net profit margin
-61.55%
Measures profitability relative to shareholders' equity
-114.38%
ROE excluding intangible assets
-20.60%
Measures profitability relative to total assets
-27.21%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
0.09
Inventory turnover ratio
0.52
Receivables turnover ratio
172.45
Average number of days it takes to collect receivables
-3.58
Measures valuation relative to earnings
-
P/E based on future earnings estimates
38.38
Measures valuation relative to sales
0.61
Measures valuation relative to book value
-0.14
Measures valuation relative to operating cash flow
-0.45
Measures valuation relative to free cash flow
-0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
